ENDRA Life Sciences Corrects 10-K Auditor Report Details
Ticker: NDRA · Form: 10-K/A · Filed: Apr 7, 2025 · CIK: 1681682
| Field | Detail |
|---|---|
| Company | Endra Life Sciences INC. (NDRA) |
| Form Type | 10-K/A |
| Filed Date | Apr 7, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, auditor-report, filing-correction
TL;DR
ENDRA Life Sciences fixed a typo in their 10-K auditor report. No big deal, just cleaning up.
AI Summary
ENDRA Life Sciences Inc. filed an amendment (Amendment No. 1) to its 2024 Form 10-K on April 7, 2025, to correct a typographical error in the auditor's report from RBSM LLP. The error involved the omission of the report date and RBSM LLP's PCAOB ID number, which were inadvertently left out during EDGAR preparation.
Why It Matters
This filing ensures the accuracy and completeness of the company's financial reporting, specifically regarding the auditor's attestation, which is crucial for investor confidence.
Risk Assessment
Risk Level: low — The amendment addresses a minor typographical error in the auditor's report and does not indicate any new material risks or changes to the company's financial health.
Key Players & Entities
- ENDRA Life Sciences Inc. (company) — Filer of the 10-K/A
- RBSM LLP (company) — Independent auditor for ENDRA Life Sciences Inc.
- April 7, 2025 (date) — Filing date of the amendment
- December 31, 2024 (date) — Fiscal year end for the original 10-K report
- March 31, 2025 (date) — Original filing date of the 10-K
FAQ
What specific typographical error was corrected in the auditor's report?
The typographical error involved the omission of the date of the Auditor's Report and RBSM LLP's PCAOB ID number.
When was the original 10-K report filed?
The original 10-K report for the year ended December 31, 2024, was filed on March 31, 2025.
What is the purpose of this Amendment No. 1 filing?
The purpose is to correct a typographical error in the auditor's report concerning the report date and the auditor's PCAOB ID number.
Who is the independent auditor for ENDRA Life Sciences Inc. for the fiscal year ended December 31, 2024?
The independent auditor is RBSM LLP.
Does this amendment change any other part of the original 10-K filing?
No, the amendment states that there have been no changes to the text of Item 8 of the Form 10-K other than the corrections related to the auditor's report.
Filing Details
This Form 10-K/A (Form 10-K/A) was filed with the SEC on April 7, 2025 regarding ENDRA Life Sciences Inc. (NDRA).